article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA. The post A new dawn of the genomic age: five areas set to be transformed in 2023 appeared first on.

Genome 126
article thumbnail

Why genomic healthcare data matters in the development of new therapies 

Drug Discovery World

One might argue that this all started getting exciting with the launch of the Human Genome Project, which the National Human Genome Research Institute consider to be one of the greatest scientific feats in history 1. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact. .

Genome 98
article thumbnail

Q&A: Gene therapy opportunities from long-read sequencing 

Drug Discovery World

The key difference between the two technologies is that long-read sequences are more effective at unambiguously determining how all the pieces of a sequenced genome fit together. This study is also part of our broader efforts to demonstrate the use case of long read sequencing in identifying rare diseases.